2018 American Transplant Congress
Pharmacogenetics of CYP3A4, CYP3A5, CYP2C8 and CYP2C19 and Their Influence on Tacrolimus Pharmacokinetics in Renal Transplant Recipients
Urology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China.
Tacrolimus (TAC) is an established essential immunosuppressive agent for renal transplant recipients. Our study aims to investigate the pharmacogenetics of CYP3A4, CYP3A5, CYP2C8 and CYP2C19…2018 American Transplant Congress
Once-Daily versus Twice-Daily Tacrolimus in De Novo Living Kidney Transplantation Patients: A Multicenter, Parallel Group, Open-Label, 5-Year Randomized Noninferiority Trial
BackgroundTacrolimus is available as twice-daily (TAC-BID) and once-daily (TAC-QD) formulations. Findings from pharmacokinetic and short-term trials are available. However, results from long-term trials are limited.We…2018 American Transplant Congress
Long-Term Effect of BMI on Renal Function in Asian Living Kidney Donors
One of the targets of expanding criteria for kidney donation is BMI. As the impact of BMI differs in Asians, we studied the long-term effect…2018 American Transplant Congress
Graft Failure in Recurrent IgA Nephropathy Following Living Kidney Transplantation: Predictive Factors Analysis of 102 Biopsies
Aim To investigate the predictive factors related to graft failure in recurrentIgA nephropathy (IgAN) following living kidney transplantation. Methods We identified a series of 102…2018 American Transplant Congress
Benefit of Patient Portal Usage in Non-High Risk Kidney Transplant Recipients
Surgery, Alpert Medical School of Brown University, Providence, RI.
Background: With widespread adoption of EHR (electronic health record), patients have access to a patient portal where they can view and thereby help monitor their…2018 American Transplant Congress
Long-Term Follow-Up of Pediatric Kidney Recipients Who Received Alemtuzumab Induction
Introduction: Experience with alemtuzumab (alem) depleting antibody induction has rarely been studied in the pediatric population, and reports that exist have limited follow-up. The purpose…2018 American Transplant Congress
The Role of Resilience in Healthcare Transitions among Adolescent and Young Adult Kidney Transplant Recipients
Adolescent and young adult (AYA) kidney transplant (KT) recipients experience high rates of premature allograft loss during healthcare transition (HCT). There is a critical need…2018 American Transplant Congress
Adult-Sized Kidneys Transplanted into Infants and Small Children: Outcomes after Implementing Aggressive Fluid Regimen and Medications to Support Post-Transplant Perfusion
Lucile Packard Children's Hospital, Palo Alto, CA.
Background: Risk of chronic graft ischemia secondary to hypoperfusion increases with greater disparity between donor and recipient size. At our center, the smallest recipients receive…2018 American Transplant Congress
Prognostic Value and Biological Significances of Five Long Non-Coding RNAs in Hepatocellular Carcinoma
Objectives Increasing evidence suggests that long non-coding RNA (lncRNA) plays a vital role in metastasis and development in hepatocellular carcinoma (HCC). Tumor progression severely affect…2018 American Transplant Congress
Locoregional Treatments before Liver Transplantation for Hepatocellular Carcinoma: A Cohort Study from the European Liver Transplant Registry
PurposeLocoregional treatment while on the waiting list for liver transplantation (Ltx) for hepatocellular carcinoma (HCC) has shown to improve survival. However, effect of treatment types…
- « Previous Page
- 1
- …
- 151
- 152
- 153
- 154
- 155
- …
- 211
- Next Page »